openPR Logo
Press release

Nivolumab Injection Market is Booming Worldwide (2020-2026)-Says QYResearch | AbbVie, Allergan, Ono Pharmaceutical

09-18-2020 08:03 AM CET | Advertising, Media Consulting, Marketing Research

Press release from: QY Research

Nivolumab Injection Market is Booming Worldwide

LOS ANGELES, United States: QY Research has recently published a research report titled, “Global Nivolumab Injection Market Research Report 2020". This report has been prepared by experienced and knowledgeable market analysts and researchers. It is a phenomenal compilation of important studies that explore the competitive landscape, segmentation, geographical expansion, and revenue, production, and consumption growth of the global Nivolumab Injection market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Nivolumab Injection market.

The report includes CAGR, market shares, sales, gross margin, value, volume, and other vital market figures that give an exact picture of the growth of the global Nivolumab Injection market.

Top Companies/Manufacturers:
AbbVie, Allergan, Ono Pharmaceutical, Sinopharm, Bristol-Myers Squibb,

Market Segment by Product Type: 100IU, 50IU, Other

Market Segment by Application: Unresectable Melanoma, Metastatic Melanoma, Metastatic Squamous NSCLC, Classical Hodgkin Lymphoma, Renal Cell Carcinoma, Other

Get PDF Sample Copy of the Report @

https://www.qyresearch.com/sample-form/form/1538533/global-nivolumab-injection-market

For Customization in the Report Drop Your Query Here:

https://www.qyresearch.com/customize-request/form/1538533/global-nivolumab-injection-market

Buy Now:

https://www.qyresearch.com/settlement/pre/2619dbb6d0c1610cf847e11179bad41b,0,1,global-nivolumab-injection-market

Competitive Landscape

Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Nivolumab Injection market.

Key questions answered in the report:

What is the growth potential of the Nivolumab Injection market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Nivolumab Injection industry in the years to come?
What are the key challenges that the global Nivolumab Injection market may face in the future?
Which are the leading companies in the global Nivolumab Injection market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Nivolumab Injection market
TOC

Table of Contents 1 Nivolumab Injection Market Overview
1.1 Product Overview and Scope of Nivolumab Injection
1.2 Nivolumab Injection Segment by Type
1.2.1 Global Nivolumab Injection Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 100IU
1.2.3 50IU
1.2.4 Other
1.3 Nivolumab Injection Segment by Application
1.3.1 Nivolumab Injection Sales Comparison by Application: 2020 VS 2026
1.3.2 Unresectable Melanoma
1.3.3 Metastatic Melanoma
1.3.4 Metastatic Squamous NSCLC
1.3.5 Classical Hodgkin Lymphoma
1.3.6 Renal Cell Carcinoma
1.3.7 Other
1.4 Global Nivolumab Injection Market Size Estimates and Forecasts
1.4.1 Global Nivolumab Injection Revenue 2015-2026
1.4.2 Global Nivolumab Injection Sales 2015-2026
1.4.3 Nivolumab Injection Market Size by Region: 2020 Versus 2026 2 Global Nivolumab Injection Market Competition by Manufacturers
2.1 Global Nivolumab Injection Sales Market Share by Manufacturers (2015-2020)
2.2 Global Nivolumab Injection Revenue Share by Manufacturers (2015-2020)
2.3 Global Nivolumab Injection Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Nivolumab Injection Manufacturing Sites, Area Served, Product Type
2.5 Nivolumab Injection Market Competitive Situation and Trends
2.5.1 Nivolumab Injection Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Nivolumab Injection Players (Opinion Leaders) 3 Nivolumab Injection Retrospective Market Scenario by Region
3.1 Global Nivolumab Injection Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Nivolumab Injection Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Nivolumab Injection Market Facts & Figures by Country
3.3.1 North America Nivolumab Injection Sales by Country
3.3.2 North America Nivolumab Injection Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Nivolumab Injection Market Facts & Figures by Country
3.4.1 Europe Nivolumab Injection Sales by Country
3.4.2 Europe Nivolumab Injection Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Nivolumab Injection Market Facts & Figures by Region
3.5.1 Asia Pacific Nivolumab Injection Sales by Region
3.5.2 Asia Pacific Nivolumab Injection Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Nivolumab Injection Market Facts & Figures by Country
3.6.1 Latin America Nivolumab Injection Sales by Country
3.6.2 Latin America Nivolumab Injection Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Nivolumab Injection Market Facts & Figures by Country
3.7.1 Middle East and Africa Nivolumab Injection Sales by Country
3.7.2 Middle East and Africa Nivolumab Injection Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E 4 Global Nivolumab Injection Historic Market Analysis by Type
4.1 Global Nivolumab Injection Sales Market Share by Type (2015-2020)
4.2 Global Nivolumab Injection Revenue Market Share by Type (2015-2020)
4.3 Global Nivolumab Injection Price Market Share by Type (2015-2020)
4.4 Global Nivolumab Injection Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Nivolumab Injection Historic Market Analysis by Application
5.1 Global Nivolumab Injection Sales Market Share by Application (2015-2020)
5.2 Global Nivolumab Injection Revenue Market Share by Application (2015-2020)
5.3 Global Nivolumab Injection Price by Application (2015-2020) 6 Company Profiles and Key Figures in Nivolumab Injection Business
6.1 AbbVie
6.1.1 Corporation Information
6.1.2 AbbVie Description, Business Overview and Total Revenue
6.1.3 AbbVie Nivolumab Injection Sales, Revenue and Gross Margin (2015-2020)
6.1.4 AbbVie Products Offered
6.1.5 AbbVie Recent Development
6.2 Allergan
6.2.1 Allergan Nivolumab Injection Production Sites and Area Served
6.2.2 Allergan Description, Business Overview and Total Revenue
6.2.3 Allergan Nivolumab Injection Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Allergan Products Offered
6.2.5 Allergan Recent Development
6.3 Ono Pharmaceutical
6.3.1 Ono Pharmaceutical Nivolumab Injection Production Sites and Area Served
6.3.2 Ono Pharmaceutical Description, Business Overview and Total Revenue
6.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Ono Pharmaceutical Products Offered
6.3.5 Ono Pharmaceutical Recent Development
6.4 Sinopharm
6.4.1 Sinopharm Nivolumab Injection Production Sites and Area Served
6.4.2 Sinopharm Description, Business Overview and Total Revenue
6.4.3 Sinopharm Nivolumab Injection Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Sinopharm Products Offered
6.4.5 Sinopharm Recent Development
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Nivolumab Injection Production Sites and Area Served
6.5.2 Bristol-Myers Squibb Description, Business Overview and Total Revenue
6.5.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Bristol-Myers Squibb Products Offered
6.5.5 Bristol-Myers Squibb Recent Development 7 Nivolumab Injection Manufacturing Cost Analysis
7.1 Nivolumab Injection Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Nivolumab Injection
7.4 Nivolumab Injection Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Nivolumab Injection Distributors List
8.3 Nivolumab Injection Customers 9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis 10 Global Market Forecast
10.1 Global Nivolumab Injection Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Nivolumab Injection by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Nivolumab Injection by Type (2021-2026)
10.2 Nivolumab Injection Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Nivolumab Injection by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Nivolumab Injection by Application (2021-2026)
10.3 Nivolumab Injection Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Nivolumab Injection by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Nivolumab Injection by Region (2021-2026)
10.4 North America Nivolumab Injection Estimates and Projections (2021-2026)
10.5 Europe Nivolumab Injection Estimates and Projections (2021-2026)
10.6 Asia Pacific Nivolumab Injection Estimates and Projections (2021-2026)
10.7 Latin America Nivolumab Injection Estimates and Projections (2021-2026)
10.8 Middle East and Africa Nivolumab Injection Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

About Us:

QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.

Contact Us:-

QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA – 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com

Web:
http://www.qyresearch.com

-

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nivolumab Injection Market is Booming Worldwide (2020-2026)-Says QYResearch | AbbVie, Allergan, Ono Pharmaceutical here

News-ID: 2136776 • Views:

More Releases from QY Research

Global and U.S. Car Exhaust Emission Analyzers Market Report, Published by QY Research.
Global and U.S. Car Exhaust Emission Analyzers Market Report, Published by QY Re …
QY Research has released a comprehensive new market report on Car Exhaust Emission Analyzers, are instruments used to measure and monitor the pollutants emitted from internal combustion engines, including carbon monoxide (CO), carbon dioxide (CO2), hydrocarbons (HC), nitrogen oxides (NOx), and oxygen (O2). They are essential for vehicle emissions testing, regulatory compliance, engine tuning, and environmental monitoring. https://www.qyresearch.com/reports/5536960/car-exhaust-emission-analyzers Core Market Data Global market size: USD 1.0 billion CAGR (2024-2030): 5.3% Average price: USD 4000 per
How Temperature-Responsive Polymers Are Transforming Precision Drug Delivery
How Temperature-Responsive Polymers Are Transforming Precision Drug Delivery
A biomedical materials company significantly improved drug-delivery precision and process efficiency after integrating Temperature-Responsive Polymers into its controlled-release formulation platform. These smart polymers-also known as thermoresponsive polymers-exhibit a reversible phase transition at a defined critical temperature (LCST or UCST), enabling predictable changes in solubility, permeability, or mechanical behavior in response to temperature variation. Materials such as poly(N-isopropylacrylamide) (PNIPAM) and its copolymers are widely used to enable on-demand drug release, cell
Global and U.S. Resistive Strain Gauge Sensors Market Report, Published by QY Research.
Global and U.S. Resistive Strain Gauge Sensors Market Report, Published by QY Re …
QY Research has released a comprehensive new market report on Resistive Strain Gauge Sensors, precision sensing elements that convert mechanical deformation into measurable electrical resistance changes. As foundational components in force, load, pressure, and torque measurement systems, resistive strain gauges are widely used across industrial automation, civil infrastructure monitoring, aerospace testing, automotive validation, and scientific research. With rising demand for high-accuracy structural monitoring, lightweight sensing solutions, and reliable long-term measurement
Top 30 Indonesian Public Manufacturing Companies Q3 2025 Revenue & Performance
1) Overall companies performance (Q3 2025 snapshot) Q3-2025 showed a mixed recovery across Indonesian manufacturing subsectors: Auto & heavy equipment: improving vehicle sales & financing activity helped conglomerates with auto exposure (Astra) and heavy-equipment vendors, though some mining/commodity segments weighed on margins. Consumer staples & FMCG: food processors and household goods makers (Indofood, Unilever Indonesia, Kalbe) were broadly resilient domestic demand and agribusiness price pass-through helped toplines. Petrochemicals: Chandra Asri reported very strong revenue

All 5 Releases


More Releases for Nivolumab

Top Trends Transforming the Nivolumab Market Landscape in 2025: Innovative Drug …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Nivolumab Industry Market Size Be by 2025? The market for nivolumab has seen a significant surge in the past few years. Its size is predicted to increase from $1.69 billion in 2024 to $1.92 billion in 2025, with a compound annual growth rate (CAGR) of 13.7%.
Nivolumab Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportuni …
The Nivolumab Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Projected Growth of the Nivolumab Market? In the past few years, the market size for nivolumab has seen quick expansion. The market is project to increase from $1.69 billion in 2024 to $1.94
Elevated Cancer Prevalence Fuels Expansion Of The Nivolumab Market Driver: Leadi …
How Are the key drivers contributing to the expansion of the nivolumab market? The nivolumab market is likely to see significant growth due to the increasing instances of cancer. Cancer, a category of diseases that can affect virtually any organ or tissue in the body, is triggered when rogue cells grow uncontrollably, disregarding their established boundaries and invading or spreading to other parts of the body. Nivolumab, a medication used to
Nivolumab Market expected to reach USD 2,736.83 million by 2030
This Nivolumab market report has been prepared by considering several fragments of the present and upcoming market scenario. The market insights gained through this market research analysis report facilitates more clear understanding of the market landscape, issues that may interrupt in the future, and ways to position definite brand excellently. It consists of most-detailed market segmentation, thorough analysis of major market players, trends in consumer and supply chain dynamics, and
Nivolumab Market Share, Industry Analysis And Forecast 2033
The new report published by The Business Research Company, titled Nivolumab Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends. As per the report, the nivolumab market size has grown rapidly in recent years. It will grow from $1.47 billion in 2023 to $1.69
Nivolumab Global Market Analysis, Trends, Growth, Research And Forecast 2033
The nivolumab market size has grown rapidly in recent years. It will grow from $1.47 billion in 2023 to $1.69 billion in 2024 at a compound annual growth rate (CAGR) of 15.1%. The growth in the historic period can be attributed to immunotherapy advancements, increased incidence of cancer, clinical trial success, regulatory approvals. The nivolumab market size is expected to see rapid growth in the next few years. It